SLV GPW sWIG80 Periodic report · PAP Biznes
Selvita (SLV) · Q1 2026 results
Share price: 17.06 zł · 2026-11-10
Results Q1 2026 vs Q1 2025 · year over year · published 21 May 2026 and 22 May 2025
Net loss widened year on year. The language turned more cautious.
Only a basic analysis is available for this company at the moment.
1 · Numbers
Loss widened
Net income vs Q1 2025
Net income -5.4M vs -986.0K
Revenue −15.9%
2 · How the report reads
More cautious
Language tone vs last period
Report language: typical for a company report — more cautious than in Q1 2025.
Weak signal: formal report language, not a call.
3 · What stood out
Key theme
The number of liabilities excluding loans and borrowings changed from 3,848 to 1,940 items.
Read between the lines
No major shifts flagged this period.
Tone
How upbeat the language was, compared with other companiesiTone counts positive minus negative finance words, adjusted for length. Executives mostly speak positively, so the labels compare each call with every company's latest call: “typical” is the middle third, “very upbeat” the top tenth, “cautious” the bottom tenth.. Dot: Q1 2026. Ring: Q1 2025.
Typical for a company report — more cautious than in Q1 2025. Periodic reports carry legally required risk wording, so their tone moves little and is a weak signal.
Sentences that drove the tone
“Increasing the potential and competitiveness of the Polish economy in the field of innovative therapies and medicines of the future, through the development of a Research and Development Center and the development of research methods and tools, as a response to social needs in the area of...”
“Description of factors and events, in particular of an unusual nature, that have a significant impact on the achieved results of the measurement of financial assets and financial liabilities...”
“Most surveys of management from pharmaceutical and biotech companies indicate that the growth in China's share was driven primarily by an increase in transactions, rather than by the displacement of activity...”
Full figures
PLN · PAP Biznes report (2026-05-21)
| Metric | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | 76.0M | 90.3M | −15.9% |
| EBITDA | 11.2M | 14.1M | −20.7% |
| Operating income | -1.8M | 277.0K | Turned loss |
| Net income | -5.4M | -986.0K | Loss widened |
| EPS | -0.30 | -0.05 | Loss widened |
| P/E today 551.2 | 757.5 | 12-mo loss | — |
Topics
Topics are drawn from the full report text, not management commentary.
Most discussed now
- Unallocated assets include: investment in Ardigen S.A., assets from deferred tax not assigned in the steps above, and public-law…
- Scope: Broad panel of in vitro tests for characterizing the ADME properties of investigated chemical compounds, in vivo pharmacokinetic…
- New The indicators of the six biotechnology IPOs, which collectively raised capital in the sector (job cuts, financial problems)
- Events that occurred after the date on which the interim financial report was prepared, not included in this report, and which may…
- Increasing the potential and competitiveness of the Polish economy in the field of innovative therapies and medicines of the future
Faded since Q1 2025
- Fading 1 Net sales revenue from products (product structure - types of activity)
- Fading During the period covered by the financial statements, the Group incurred contingent liabilities necessary to receive the grant and the…
- Fading Depreciation Increase in fixed assets ended in thousands
Latest announcements
Official filings, newest first.
- Rejestracja zmian Statutu Spółki / Registration of Amendments to the Company's Articles of Association · ESPI 24/2026
- Korekta raportu bieżącego nr 23/2026 / Correction of the Current Report No. 23/2026 · ESPI 23/2026
- Uzgodnienie i podpisanie Planu Połączenia spółek zależnych / Agreement and Execution of the Merger Plan by Subsidiaries · ESPI 23/2026
- Zmiany w Zarządzie i Radzie Nadzorczej Selvita S.A. / Changes in the Management Board and Supervisory Board of Selvita S.A. · ESPI 22/2026
- Half-year report · ESPI periodic
- Otrzymanie istotnego zlecenia / Receipt of a Significant Order · ESPI 21/2026
- Rezygnacja Członka Zarządu / Resignation of a Management Board Member · ESPI 20/2026
- Wykaz akcjonariuszy posiadających co najmniej 5% liczby głosów na Zwyczajnym Walnym Zgromadzeniu Selvita S.A. w dniu 24 czerwca 2026 r. / Shareholders Controlling at Least 5% of the Votes at the General Shareholders Meeting of Selvita S.A. Convened on Jun · ESPI 19/2026